Sohaila Andleeb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sohaila Andleeb has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Ihsan‐Ul Haq
Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan
1 shared publication- Imtiaz- Ud- Din
Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
1 shared publication - Irum Asif
Department of Environmental Sciences, Fatima Jinnah Women University, Rawalpindi, Pakistan
1 shared publication Mahnoor Saleem
Institute of Chemistry, University of Sargodha, Sargodha, Pakistan
1 shared publication- Muhammad Khawar Rauf
Department of Chemistry, Quaid-i-Azam University, Islamabad, Pakistan
1 shared publication Muhammad Nawaz Tahir
Department of Physics, University of Sargodha, Sargodha, Pakistan
1 shared publication
Latest Publications
- 23 October 2026
- Published by Springer Nature in Journal of Solution Chemistry
- p. 1-41
Recent Advances in Molecular Design and Applications of Ionic Liquids
- 23 October 2026
- Published by Springer Nature in Journal of Solution Chemistry
- p. 1-41
Recent Advances in Molecular Design and Applications of Ionic Liquids
- 4 January 2022
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 27 (1) , 175-187
Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies
In a quest to discover new formulations for the treatment of various parasitic diseases, a series of heteroleptic triorganobismuth(V) biscarboxylates of type [BiR3(O2CR′)2], where R=C6H5 for 1–4 and p-CH3C6H4 for 5–8, were synthesized, characterized and evaluated for their biological potential against L. tropica. All the synthesized complexes were fully characterized by elemental analysis, FT-IR, multinuclear (1H and 13C) NMR spectroscopy and X-ray crystallography. The crystal structures for [BiPh3(O2CC6H4(o-Br))2] (1), [BiPh3(O2CC2H2C6H4)2] (2), [BiPh3(O2CC6H4(m-NO2))2] (3) and [BiPh3(O2CC6H4(2-OH,3-CH3))2] (4) were determined and found to have a distorted pentagonal bipyramidal molecular geometry with seven coordinated bismuth center for 1–3 and for 4 distorted octahedral geometry, respectively. All the synthesized complexes demonstrated a moderate to significant activity against leishmania parasites. A broad analytical approach was followed to testify the stability for (1–8) in solid state as well as in solution and in leishmanial culture M199, ensuring them to be stable enough to exert a significant antileishmanial effect with promising results. Cytotoxicity profile suggests that tris(tolyl) derivatives show lower toxicity against isolated lymphocytes with higher antileishmanial potential. Molecular docking studies were carried out to reveal the binding modes for (1–8) targeting the active site of trypanothione reductase (TR) (PDB ID: 4APN) and Trypanothione Synthetase-Amidase structure (PDB ID 2vob). Graphical abstract
- 4 January 2022
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 27 (1) , 175-187
Structural characterization and antileishmanial activity of newly synthesized organo-bismuth(V) carboxylates: experimental and molecular docking studies
In a quest to discover new formulations for the treatment of various parasitic diseases, a series of heteroleptic triorganobismuth(V) biscarboxylates of type [BiR3(O2CR′)2], where R=C6H5 for 1–4 and p-CH3C6H4 for 5–8, were synthesized, characterized and evaluated for their biological potential against L. tropica. All the synthesized complexes were fully characterized by elemental analysis, FT-IR, multinuclear (1H and 13C) NMR spectroscopy and X-ray crystallography. The crystal structures for [BiPh3(O2CC6H4(o-Br))2] (1), [BiPh3(O2CC2H2C6H4)2] (2), [BiPh3(O2CC6H4(m-NO2))2] (3) and [BiPh3(O2CC6H4(2-OH,3-CH3))2] (4) were determined and found to have a distorted pentagonal bipyramidal molecular geometry with seven coordinated bismuth center for 1–3 and for 4 distorted octahedral geometry, respectively. All the synthesized complexes demonstrated a moderate to significant activity against leishmania parasites. A broad analytical approach was followed to testify the stability for (1–8) in solid state as well as in solution and in leishmanial culture M199, ensuring them to be stable enough to exert a significant antileishmanial effect with promising results. Cytotoxicity profile suggests that tris(tolyl) derivatives show lower toxicity against isolated lymphocytes with higher antileishmanial potential. Molecular docking studies were carried out to reveal the binding modes for (1–8) targeting the active site of trypanothione reductase (TR) (PDB ID: 4APN) and Trypanothione Synthetase-Amidase structure (PDB ID 2vob). Graphical abstract